Last updated: 29 June 2019 at 2:15am EST

Jerome Goldstein Net Worth




The estimated Net Worth of Jerome Goldstein is at least $24.5 Milion dollars as of 30 April 2007. Jerome Goldstein owns over 20,000 units of AMAG Pharmaceuticals stock worth over $4,756,300 and over the last 18 years Jerome sold AMAG stock worth over $19,702,585.

Jerome Goldstein AMAG stock SEC Form 4 insiders trading

Jerome has made over 15 trades of the AMAG Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Jerome sold 20,000 units of AMAG stock worth $1,329,600 on 30 April 2007.

The largest trade Jerome's ever made was selling 50,000 units of AMAG Pharmaceuticals stock on 11 September 2006 worth over $1,708,000. On average, Jerome trades about 29,207 units every 17 days since 2006. As of 30 April 2007 Jerome still owns at least 190,252 units of AMAG Pharmaceuticals stock.

You can see the complete history of Jerome Goldstein stock trades at the bottom of the page.



What's Jerome Goldstein's mailing address?

Jerome's mailing address filed with the SEC is C/O ADVANCED MAGNETICS, INC., 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140.

Insiders trading at AMAG Pharmaceuticals

Over the last 18 years, insiders at AMAG Pharmaceuticals have traded over $162,079,471 worth of AMAG Pharmaceuticals stock and bought 3,622,220 units worth $65,172,892 . The most active insiders traders include Capital, Llc Armistice Capi..., Capital Partners Gp, L.L.C.... oraz Capital Management Lp Camber. On average, AMAG Pharmaceuticals executives and independent directors trade stock every 42 days with the average trade being worth of $2,148,850. The most recent stock trade was executed by Capital Management Lp Camber on 1 October 2020, trading 4,390,000 units of AMAG stock currently worth $59,572,300.



What does AMAG Pharmaceuticals do?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.



What does AMAG Pharmaceuticals's logo look like?

AMAG Pharmaceuticals, Inc. logo

Complete history of Jerome Goldstein stock trades at AMAG Pharmaceuticals

Data
#
Firma
Osoba
Trans.
Transakcja
Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
30 Apr 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 20,000 $66.48 $1,329,600
30 Apr 2007
190,252
23 Apr 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 20,000 $68.69 $1,373,800
23 Apr 2007
200,252
16 Apr 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 20,000 $70.71 $1,414,200
16 Apr 2007
210,252
9 Apr 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 20,000 $64.75 $1,295,000
9 Apr 2007
220,252
2 Apr 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 20,000 $60.33 $1,206,600
2 Apr 2007
230,242
26 Mar 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 10,000 $60.03 $600,300
26 Mar 2007
105,108
23 Jan 2007 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 40,000 $56.24 $2,249,600
23 Jan 2007
110,108
21 Nov 2006 Jerome Goldstein
CEO i Skarbnik
Opcja Ćwiczenie 6,250 $5.65 $35,313
21 Nov 2006
94,760
11 Sep 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $34.16 $1,708,000
11 Sep 2006
101,087
5 Sep 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $36.26 $1,813,000
5 Sep 2006
126,087
29 Aug 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 11,054 $35.28 $389,985
29 Aug 2006
269,473
21 Aug 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $31.61 $1,580,500
21 Aug 2006
275,000
7 Aug 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $31.24 $1,562,000
7 Aug 2006
300,000
7 Aug 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $32.46 $1,623,000
7 Aug 2006
325,000
31 Jul 2006 Jerome Goldstein
CEO i Skarbnik
Sprzedaż 50,000 $31.14 $1,557,000
31 Jul 2006
350,000


AMAG Pharmaceuticals executives and stock owners

AMAG Pharmaceuticals executives and other stock owners filed with the SEC include: